• Home
  • Sites
  • News
  • Publications
  • Contact

Publications

BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years Clinical Infectious Diseases August 4, 2022
Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C Pediatrics June 29, 2022
Treatment of Multisystem Inflammatory Syndrome in Children: Understanding Differences in Results of Comparative Effectiveness Studies ACR Open June 27, 2022
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants New England Journal of Medicine June 22, 2022
Preliminary data reported in MMWR: Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022 Morbidity and Mortality Weekly Report February 15, 2022
Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children Clinical Infectious Diseases June 19, 2022
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C Nature Communications May 27, 2022
BNT162b2 Protection against the Omicron Variant in Children and Adolescents New England Journal of Medicine March 30, 2022
Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay Clinical Infectious Diseases February 25, 2022
Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and MIS-C Vaccines February 10, 2022
Immunology of SARS-CoV-2 infection in children Nature Immunology February 1, 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021 Morbidity and Mortality Weekly Report January 14, 2022
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents New England Journal of Medicine January 12, 2022
Preliminary data reported in MMWR: Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021 Morbidity and Mortality Weekly Report October 22, 2021
A Description of COVID-19-Directed Therapy in Children Admitted to US Intensive Care Units 2020 Journal of the Pediatric Infectious Disease Society January 12, 2022
Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants Pediatric Infectious Disease Journal December 21, 2021
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents EClinicalMedicine August 31, 2021
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes New England Journal of Medicine June 16, 2021
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome JAMA Neurology March 5, 2021
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 Journal of the American Medical Association February 24, 2021
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents New England Journal of Medicine June 29, 2020
Overcoming COVID-19 Copyright 2020 © All rights reserved.
Legal and Privacy Policy
Note: We are unable to provide clinical advice. If you have specific questions about your child’s health or clinical care, please contact their healthcare provider. Privacy Policy
Contact
contact@overcomecovid.org
Website Designed by Cameron Young
Investigators Portal

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories

Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.